Anhydrous crystalline fexofenadine hydrochloride Form C, crystallinefexofenadine acetate monohydrate Form D, crystalline fexofenadine acetatedihydrate Form E and crystalline fexofenadine free base monohydrate Form F,processes of preparing the same, pharmaceutical compositions thereof,therapeutic uses thereof and methods of treatment therewith.